Inhibikase Therapeutics Inc at ASENT Neurotherapeutics Conference (Virtual) Transcript
Well, I want to thank the organizers of ASENT for inviting Inhibikase to present some of its work related to its therapeutics and development to halt and reverse the effects of neurodegeneration and Parkinson's disease.
Just because we are a public company, I need to display this disclaimer. I'll make forward-looking statements and respective statements about our research programs. But I refer everyone that may be interested to evaluate the underlying basis of the statements in our public filings with the Securities and Exchange Commission.
So if we were to look at the way Inhibikase has gone about understanding Parkinson's disease, what we believe I will show evidence for today, is how we are going to drive functional, reversible disease in living patients. While we have a multi-therapeutic pipeline and neurodegeneration oncology in infectious disease, it really sits on the cutting edge of that science.
And the way we've been able to evaluate that cutting edge and work in both basic research and in translation
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
